Related references
Note: Only part of the references are listed.Extracellular vesicles for drug delivery
Pieter Vader et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
Talia Golan et al.
ONCOTARGET (2015)
Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter
Charles P. Lai et al.
ACS NANO (2014)
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
Roy van der Meel et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic cancer
Linjuan Zeng et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles
Sander A. A. Kooijmans et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
Minimal Self Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Pia L. Rodriguez et al.
SCIENCE (2013)
K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment
Soukaina Rejiba et al.
CANCER SCIENCE (2007)
Share Paper
